What’s New in Hip Replacement 2021
Every month, JBJS publishes a review of the most pertinent and impactful studies from the orthopaedic literature during the previous …
More Data on Outpatient vs Inpatient Joint Replacement
In addition to the Pearl Diver-based retrospective study by Arshi et al. on one-year complications after outpatient knee replacement, …
Total Joint Arthroplasty: Does One Lead to Another?
An estimated 7 million people living in the US have undergone a total joint arthroplasty (TJA), and the demand for …
What’s New in Hip Replacement
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature …
Cobalt-Ion Thresholds Could Ease Follow-Up Burden on Some MoM Patients
In the mid-2000s, before the orthopaedic community was aware of the potentially catastrophic shortcomings of metal-on-metal (MoM) hip implants, nearly …
New Studies on BMI and Hip Replacement
Obesity is one of the most serious public health problems in the 21st century, and body weight is becoming …
3-D Planning Enhances Cup-Placement Accuracy in THA
When it comes to acetabular cup positioning during total hip arthroplasty (THA), precision really matters. Malpositioned cups increase the risk …
What’s New in Orthopaedic Rehabilitation: Level I and II Studies
Every month, JBJS publishes a Specialty Update—a review of the most pertinent and impactful studies published in the orthopaedic literature …
FDA Approves Pradaxa for Thromboprevention After Hip Replacement
The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval …